Genmab A GNMSF
NASDAQ GNMSF
$337.00 +2.00 (+0.60%)
As of: Aug 21, 2026 · 10:11 AM EDT

Genmab A/S (GNMSF) Times Interest Earned (2019 - 2026)

Genmab A's (GNMSF) quarterly Times Interest Earned came in at -$1.2 in Q1 2026, up 71.28% YoY from -$0.7 in Q1 2025, and up 79.74% on a QoQ basis from -$5.92 in Q3 2025.

Genmab A/S (GNMSF) Times Interest Earned (2019 - 2026) Analysis & Trends

Genmab A (GNMSF) has 5 years of Times Interest Earned data on file, last reported at -$1.2 in Q1 2026.

  • Quarterly Times Interest Earned rose 71.28% year-over-year to -$1.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.34 (down 21.59% YoY) and the FY2025 annual result came in at $3.96, up 18.53% from the prior year.
  • Times Interest Earned grew to -$1.2 in Q1 2026, from -$5.92 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $4.4 in Q2 2024 to a low of -$5.92 in Q3 2025.
  • A 3-year average of -$1.4 and a median of -$3.31 in 2024 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2025 — Times Interest Earned tumbled 61.96% — and 2026, when it surged 71.28%.
  • Tracing GNMSF's Times Interest Earned over 3 years: stood at -$3.66 in 2024, then tumbled by 61.96% to -$5.92 in 2025, then jumped by 79.74% to -$1.2 in 2026.
  • The last three Times Interest Earned figures came in at -$1.2 (Q1 2026), -$5.92 (Q3 2025), and $4.09 (Q2 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 2.70
Mar 31, 2026 -1.20
Sep 30, 2025 -5.92
Jun 30, 2025 4.09
Mar 31, 2025 -4.18
Sep 30, 2024 -3.66
Jun 30, 2024 4.40
Mar 31, 2024 -3.31
Sep 30, 2020 0.07
Dec 31, 2019 -86.38